Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A novel SRSF3 inhibitor, SFI003, exerts anticancer activity against colorectal cancer by modulating the SRSF3/DHCR24/ROS axis
Yawen Zhang, Mengmeng Wang, Fanyi Meng, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
Ali Doostmohammadi, Hossein Jooya, Kimia Ghorbanian, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 32
Towards understandings of serine/arginine-rich splicing factors
D. Li, Wenying Yu, Maode Lai
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3181-3207
Open Access | Times Cited: 31
SR proteins in cancer: function, regulation, and small inhibitor
Mingrong Bei, Jianzhen Xu
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Tumor-promoting effect and tumor immunity of SRSFs
Shuai Zhang, Yongxi Zhang, Sijia Feng, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
The Role of Cholesterol Metabolism and Its Regulation in Tumor Development
Yongmei Wu, Wenqian Song, Su Min, et al.
Cancer Medicine (2025) Vol. 14, Iss. 7
Open Access
DHCR24 in Tumor Diagnosis and Treatment: A Comprehensive Review
Xin Fu, Zhaosong Wang
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 3
Serine-arginine protein kinases and their targets in viral infection and their inhibition
Kai Zheng, Zhe Ren, Yifei Wang
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 6
Open Access | Times Cited: 8
Oncogenic SRSF3 in health and diseases
Rong Jia, Zhi‐Ming Zheng
International Journal of Biological Sciences (2023) Vol. 19, Iss. 10, pp. 3057-3076
Open Access | Times Cited: 8
Insights into established and emerging roles of SR protein family in plants and animals
Kundan Kumar, Shubham Kumar Sinha, Upasana Maity, et al.
Wiley Interdisciplinary Reviews - RNA (2022) Vol. 14, Iss. 3
Closed Access | Times Cited: 13
Targeting serine- and arginine-rich splicing factors to rectify aberrant alternative splicing
Dianyang Li, Wenying Yu, Maode Lai
Drug Discovery Today (2023) Vol. 28, Iss. 9, pp. 103691-103691
Closed Access | Times Cited: 5
Rationally designed inhibitors of the Musashi protein-RNA interaction by hotspot mimicry
Nan Bai, Yusuf Adeshina, Igor Bychkov, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 4
Homeobox B9 Promotes Colon Cancer Progression by Targeting SRSF3
Lebin Yuan, Fei Cheng, Zhao Wu, et al.
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 8, pp. 3324-3340
Closed Access | Times Cited: 4
Rationally designed inhibitors of the Musashi protein-RNA interaction by hotspot mimicry
Nan Bai, Yusuf Adeshina, Igor Bychkov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
24-Dehydrocholesterol Reductase Facilitates Cisplatin Resistance of Non-small Cell Lung Cancer via Repressing Reactive Oxygen Species/Ferroptosis Pathway
Ce Qin, Jun Yuan, Rui Zhang, et al.
Deleted Journal (2024) Vol. 23, Iss. 1
Open Access
Inhibition of serine and arginine-rich splicing factor 3 induces epidermal differentiation and decreases cutaneous squamous cell carcinoma risk
Isoline M. Donohue, Haiyin He, Audrey Nguyen, et al.
(2024)
Closed Access
The Role of miR-1183: A Potential Suppressor in Hepatocellular Carcinoma via Regulating Splicing Factor SRSF1
Zhilu Yao, Ning Liu, Hui Lin, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1169-1180
Open Access | Times Cited: 1
SRSF3 Alleviates Ischemic Cerebral Infarction Damage by Activating the PI3K/AKT Pathway
Liangliang Cui, Shuying Zhao, Hong Liu
Developmental Neuroscience (2023) Vol. 46, Iss. 5, pp. 308-318
Open Access | Times Cited: 1
Emerging roles of alternative RNA splicing in oral squamous cell carcinoma
Miao Liu, Jihua Guo, Rong Jia
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 1
Page 1

Scroll to top